<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Microbiology (2011), 157, 2785&#226;&#8364;&#8220;2794                                                                           DOI 10.1099/mic.0.049023-0 <br />  <br />  <br />  <br />  <br />                                          Plasmodium falciparum NIMA-related kinase <br />                                          Pfnek-1: sex specificity assessment of <br />                                          essentiality erythrocytic asexual cycle <br />                                          Dominique Dorin-Semblat,1,2 Sophie Schmitt,3 Jean-Philippe Semblat,1,2 <br />                                          Audrey Sicard,1,2 Luc Reininger,1,2 Dean Goldring,4 Shelley Patterson,5 <br />                                          Neils Quashie,6 Debopam Chakrabarti,5 Laurent Meijer3 <br />                                          Christian Doerig1,2 <br />   Correspondence                         1 <br />                                           INSERM-EPFL Joint Laboratory, Global Health Institute, Ecole Polytechnique Fe&#194;&#180;de&#194;&#180;rale de <br />   Christian Doerig                        Lausanne, GHI-SV-EPFL Station 19, CH-1015 Lausanne, Switzerland <br />   christian.doerig@epfl.ch               2 <br />                                           INSERM U609, Wellcome Trust Centre Molecular Parasitology, University Glasgow, <br />                                           Glasgow G12 8TA, UK <br />                                          3 <br />                                           Cell Cycle Group, C.N.R.S., Station Biologique, 29680 Roscoff, Bretagne, France <br />                                          4 <br />                                           Biochemistry, University Kwazulu-Natal, PB X01 Scottsville, South Africa <br />                                          5 <br />                                           Department Molecular Biology Microbiology, University Central Florida, 12722 Research <br />                                           Parkway, Orlando, FL 32826, USA <br />                                          6 <br />                                           Infection Immunity, University Glasgow, 120 University Place, Glasgow G12 8TA, UK <br />  <br />  <br />                                          The Plasmodium falciparum kinome includes family protein kinases (Pfnek-1 -4) <br />                                          related NIMA (never-in-mitosis) family, members play important roles mitosis and <br />                                          meiosis eukaryotic cells. Only these, Pfnek-1, previously characterized the <br />                                          biochemical level, expressed asexual parasites. The (Pfnek-2, -3 -4) are <br />                                          expressed predominantly gametocytes, role nek-2 nek-4 meiosis been <br />                                          documented. Here reverse genetics Pfnek-1 required completion the <br />                                          asexual cycle red blood cells expression gametocytes detectable by <br />                                          immunofluorescence male (but female) gametocytes, contrast Pfnek-2 Pfnek- <br />                                          4. This indicates function Pfnek-1 non-redundant members of <br />   Received 12 February 2011              Pfnek family identifies Pfnek-1 potential target antimalarial chemotherapy. A <br />   Revised 1 June 2011                    medium-throughput screen small-molecule library provides proof concept recombinant <br />   Accepted 5 July 2011                   Pfnek-1 used target drug discovery. <br />  <br />  <br />  <br /> INTRODUCTION                                                                receptors (Madeira et al., 2008). However, remains <br />                                                                             elucidated terms function these <br /> Proteins participating cell signalling, notably large <br />                                                                             elements play parasite&#226;&#8364;&#8482;s life cycle. Functions the <br /> families G-protein-coupled receptors protein <br />                                                                             life cycle established PKs using a <br /> kinases (PKs), constitute vast reservoir potential <br />                                                                             gene <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-164' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-180' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-190' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-192' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-195' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-201' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-202' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-224' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-228' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-232' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span>knockout</span> approach Plasmodium berghei system <br /> molecular targets chemotherapy variety diseases. <br />                                                                             (Rangarajan et al., 2005, 2006; Reininger et al., 2005, 2009; <br /> PKs ubiquitous living organisms, of <br />                                                                             Tewari et al., 2005), amenable P. <br /> pathogens represent attractive targets offer <br />                                                                             falciparum genetic manipulation (Carvalho &amp; Me&#194;&#180;nard, <br /> prospects selective inhibition. The availability of <br />                                                                             2005). This culminated kinome-wide systematic study <br /> genomic sequence databases Plasmodium falciparum <br />                                                                             identifying P. berghei PKs role transmission <br /> (Kissinger et al., 2002) allowed significant progress in <br />                                                                             (Tewari et al., 2010). In parallel, number reverse <br /> our understanding complement molecules <br />                                                                             genetics studies P. falciparum kinases been <br /> involved cell signalling malaria parasites, notably <br />                                                                             published (Abdi et al., 2010; Dorin-Semblat et al., 2007, <br /> through characterization malarial kinome <br />                                                                             2008; Dvorin et al., 2010; Fennell et al., 2009; Halbert et al., <br /> (Anamika et al., 2005; Ward et al., 2004) potential <br />                                                                             2010; Holland et al., 2009; McRobert et al., 2008; Merckx <br />                                                                             et al., 2008; Reininger et al., 2009; Taylor et al., 2010). <br /> Abbreviation: HA, haemagglutinin.                                           Taken together, sets data allow assignment of <br />  <br /> 049023 G 2011 SGM            Printed Great Britain                                                                                 2785 <br />  D. Dorin-Semblat others <br />  <br />  <br /> roles specific Plasmodium kinases processes               2583 39 end, omitting stop codon haemagglutinin <br /> parasitaemia growth rate, egress erythrocyte,                   (HA) epitope in-frame]. The 768 bp fragment amplified by <br /> stress response, gametogenesis, meiosis mosquito                  PCR genomic DNA, using Phusion polymerase, primers <br />                                                                          carrying PstI BamHI restriction sites allowed insertion the <br /> vector sporozoite infectivity, identified                 pCAM-BSD-HA vector. <br /> number kinases essential completion the <br /> erythrocytic asexual cycle (reviewed Doerig et al., 2010).            Parasite transfection. Asexual parasites 3D7 clone were <br />                                                                          grown transfected described previously (Dorin-Semblat et al., <br /> NIMA-related kinases (nimA denotes never-in-mitosis,                     2007). Briefly, transfection carried electroporation ring <br /> after <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-84' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-92' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-95' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-104' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-113' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-116' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-121' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-134' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-139' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span>phenotype</span> observed Aspergillus nidulans               stage parasites 60 mg plasmid DNA. Blasticidin added a <br /> mutant member family                     final concentration 2.5 mg ml21 48 h transfection. Resistant <br /> identified), Neks, constitute conserved family                   parasites started appear 3&#226;&#8364;&#8220;4 weeks post-transfection. <br /> enzymes crucial roles regulation mitosis and <br /> meiosis, associated centrosomes, spindle poles              Genotype analysis. PCR analysis transfectants performed <br /> and components cell division machinery (Fry                 ExTaq polymerase using genomic DNA various primer <br />                                                                          combinations. <span id='am-3' about='protege:TO' typeof='owl:Thing'>To</span> detect integration pCAM-BSD-Nek-1 the <br /> et al., 1998; O&#226;&#8364;&#8482;Regan et al., 2007; Rhee &amp; Wolgemuth,                    pfnek-1 locus, following primers used: primer 1, 59-ATGC- <br /> 1997). Of Neks represented P. falciparum                     CAAGTAAATATGATGATGG; primer 2, 59-TATTCCTAATCATGT- <br /> kinome, (Pfnek-2, Pfnek-3 Pfnek-4)                         AAATCTTAAA; primer 3, 59-CAATTAACCCTCACTAAAG; primer <br /> expressed predominantly gametocytes; line                     4, 59-GTACTGCTGTTACTATAAC. Primers 1 4 correspond to <br /> Nek functions eukaryotes, Plasmodium nek-2                  pfnek-1 sequences, primers 2 3 correspond pCAM-BSD <br /> and nek-4 enzymes shown required                          sequences flanking insertion site. <br /> completion meiosis mosquito vector (Reininger                  To verify genotype HA-Pfnek-1-transfected parasites, various <br /> et al., 2005, 2009). The NIMA family member                   combinations primers used test 39 59 boundaries the <br /> mRNA detectable microarray                          integration site. Primer 1, 59-GTCAATATAGTAATACTTCAGT; pri- <br /> erythrocytic asexual cycle (and gametocytes)                  mer 2, 59-CATGCATGTGCATGCAC; primer 3, 59-GCCATATTTTAT- <br /> Pfnek-1, enzymatic properties described pre-                    GTAATAATCATGG; primer 4, 59-GCTTATTTTGTATGATAATATA- <br /> viously using recombinant enzyme (Dorin et al., 2001).                 TATAAATAC; primer 5, 59-CAATTAACCCTCACTAAAG; primer 6, <br />                                                                          59-TATTCCTAATCATGTAAATCTTAAA. Primer 1 located the <br /> Here active Pfnek-1 enzyme                     pfnek-1 sequence lying upstream cloned amplicon, primers 3 and <br /> expressed asexual parasites. Furthermore, transgenic                  4 hybridize pfnek-139UTR, primers 2, 5 6 correspond to <br /> parasite lines expressing tagged Pfnek-1 used               pCAM-BSD sequences flanking insert. <br /> that enzyme sex-specific, expression detectable <br /> only male gametocytes. We functional                 Southern blotting. Genomic DNA isolated wild-type <br /> pfnek-1 gene required parasite <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-8' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-21' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-35' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-36' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-38' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-63' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-79' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span>survival</span>                parasites transfectants described previously (Dorin-Semblat <br /> potential target chemotherapy, provide proof                  et al., 2007). Genomic DNA (3 mg) digested SpeI NcoI. <br />                                                                          Cleaved DNA separated 0.8 % agarose gel, transferred a <br /> concept recombinant enzyme used in <br />                                                                          Hybond membrane probed pfnek-1 fragment used an <br /> medium-throughput screening campaigns identify                        insert pCAM-BSD-Nek-1 construct. For genotype analysis of <br /> inhibitors step drug discovery process.              HA-tagged transfected parasites, genomic DNA wild-type 3D7 <br />                                                                          parasites transfectants digested StuI HindIII StuI <br />                                                                          BamHI, blot probed 557 bp PCR (nucleotides <br /> METHODS                                                                  577 1155 pfnek-1 coding region). <br />  <br /> Parasite cultures. Asexual parasites gametocytes cultivated     Immunofluorescence. HA-Pfnek-1 protein expression studied <br /> in vitro described previously (Holland et al., 2009). Cultures     immunofluorescence assays cold-methanol-fixed cells. Double <br /> asexual parasites synchronized using sorbitol treatment          labelling experiments performed follows: mouse anti-HA <br /> (Lambros &amp; Vanderberg, 1979). Gametocytogenesis induced           antibody (1 : 200 dilution) incubated PBS, 1 % BSA, 0.01 % <br /> described Carter et al. (1993) gametocytes maintained        saponin 1 h. After washes PBS, secondary Alexa Fluor <br /> until stage V normal culture media. Stages monitored          488 anti-mouse antibody (1 : 1000 dilution) incubated 1 hour. <br /> Giemsa staining, smears taken immunofluorescence            Following washes, rat anti-Pfg377 (1 : 500 dilution) antibody was <br /> studies.                                                                 incubated 1 h followed incubation secondary Alexa <br />                                                                          Fluor 594 anti-rat antibody (1 : 1000 dilution). The slides were <br /> Transfection constructs. pCAM-BSD-Nek-1, plasmid designed            washed, stained DAPI 5 min mounted with <br /> for pfnek-1 gene disruption, generated inserting 557 bp DNA     Fluoromount. Labelled specimens examined Zeiss <br /> amplicon spanning nucleotides 73&#226;&#8364;&#8220;630 pfnek-1 ORF         Axioscope microscope combination Orca Digital camera. <br /> pCAM-BSD vector carrying blasticidine deaminase expression <br /> cassette (Sidhu et al., 2005). The insert obtained PCR P.    Pfnek-1 expression investigated using rabbit immunopur- <br /> falciparum genomic DNA following specific primers: forward,     ified anti-Pfnek-1 antibody immunofluorescence assay. For these <br /> 59-GGGGGATCCAGATTTGGAGAAGTATTTTTAGTA, reverse,                       assays, smears synchronized stages fixed cold acetone for <br /> 59-GGGGCGGCCGCAGGAGACCAATAGTATGGTGT. The primers                         1 min blocked 1 % BSA 1 h. The labelling performed <br /> contained BamHI NotI sites, respectively (underlined), used       30 min immunopurified antibody pre- <br /> insert PCR product pCAM-BSD. pCAM-HA-Nek-1,                 immune serum control, diluted 1 : 250 PBS, 1 % BSA. <br /> tagging plasmid, generated using pCAM-BSD-HA vector           After washes, slides incubated Alexa Fluor 594 <br /> described previously (Dorin-Semblat et al., 2007) insertion     anti-rabbit antibody (diluted 1 : 1000) 30 min. The slides were <br /> amplicon covering 39 end pfnek-1 coding region [nucleotides   washed mounted mounting solution containing <br />  <br /> 2786                                                                                                                         Microbiology 157 <br />                                                                                                         A male-specific Plasmodium kinase <br />  <br />  <br /> DAPI. Image acquisition performed Zeiss Axioplan                 Dose&#226;&#8364;&#8220;response curves performed compounds showing <br /> microscope combined Axio Cam HSM B/W camera.                      50 % inhibition 10 mM. <br /> Late-stage gametocytes (stages IV V) labelled with <br /> antibodies tubulin Pf377. Double labelling performed <br /> as rabbit anti-tubulin antibody (Sigma; 1 : 5000      RESULTS AND DISCUSSION <br /> dilution) secondary Alexa Fluor 488 anti-rabbit used <br /> (1 : 1000). Slides prepared described previously visualized   Pfnek-1 protein expression erythrocytic <br /> with Olympus Delta Vision microscope IX 71 6100 <br />                                                                           asexual cycle <br /> immersion oil objective. <br />                                                                           We showed previously Pfnek-1 transcripts detectable <br /> Immunoprecipitation. Parasite pellets obtained saponin lysis           asexual parasites gametocytes (Dorin et al., <br /> were sonicated RIPA buffer (30 mM Tris, pH 8.0, 150 mM NaCl, <br />                                                                           2001), consistent microarray analysis data available on <br /> 20 mM MgCl2, 1 mM EDTA, 10 mM ATP, 1 % Triton X-100, 0.5 % <br /> Nonidet P-40, 10 mM b-glycerophosphate, 10 mM NaF, 0.1 mM                 PlasmoDB (Le Roch et al., 2003). However, Plasmodium <br /> sodium orthovanadate, 1 mM PMSF Complex protease inhibi-              protein expression does necessarily mirror presence <br /> tors). The lysates cleared centrifugation (15 000 r.p.m.      cognate mRNA, discrepancy mRNA and <br /> 30 min 4 uC), total proteins supernatant      protein levels, caused delay translation, is <br /> was measured using Bio-Rad protein assay. For immunoprecipita-          uncommon (Le Roch et al., 2004). To verify the <br /> tion, parasite extract (300 mg) incubated ice 2 h pre-    Pfnek-1 protein expressed asexual parasites, <br /> immune serum, immunopurified rabbit anti-Pfnek-1 antibody or <br /> anti-HA mouse antibodies. The immunocomplexes precipitated <br />                                                                           rabbit chicken antibodies raised Pfnek-1- <br /> with 20 ml Protein A-Sepharose CL4B, washed times RIPA            derived peptide used Western blot analysis. Both <br /> buffer, RIPA buffer supplemented 0.1 % SDS        antibodies recognized catalytic domain Pfnek-1 <br /> with kinase buffer. Kinase assays performed immuno-           expressed Escherichia coli GST-fusion protein <br /> complexes using b-casein substrate.                                  (Dorin et al., 2001), .100 kDa band found <br />                                                                           predominantly trophozoites schizonts, is <br /> Western blotting. Protein extracts synchronized stages (rings, <br />                                                                           presumably full-<span id='am-2' about='xsp:length' typeof='owl:Thing'>length</span> Pfnek-1 (predicted molecular mass <br /> trophozoites schizonts) separated SDS-PAGE gels and <br /> transferred nitrocelullose membranes described previously         125 kDa) (Fig. 1a). Additional bands lower molecular <br /> (Dorin et al., 2005). The blots incubated immunopur-         mass visible, presumably arise processing or <br /> ified chicken antibody (1 : 1000 dilution) immunopurified      degradation. In experiments .100 kDa band was <br /> rabbit antibody (1 : 200 dilution), directed Pfnek-1       barely detectable, bulk signal provided a <br /> peptide (KRGPELPIKGKSKELN), subsequently incubated             band 49 kDa expression <span id='am-316' about='xsp:pattern' typeof='owl:Thing'>pattern</span> (Fig. 1b). <br /> rabbit anti-chicken goat anti-rabbit secondary antibody,             The size band suggests C-terminal extension is <br /> respectively, conjugated peroxidase (1 : 5000 dilution), washed <br />                                                                           cleaved Pfnek-1 molecules, leaving protein <br /> and developed using ECL detection system. To detect HA-tagged <br /> Pfnek-1, protein extracts prepared probed described           containing essentially catalytic domain; additional <br /> above. An anti-HA monoclonal peroxidase-conjugated antibody               experiments required confirm possibility. <br /> (1 : 1000 dilution, 1 h incubation) used detect HA-tagged <br /> kinase, rabbit serum anti-PfTrx1 (1 : 4000) used a <br />                                                                           We used immuno-purified rabbit anti-Pfnek-1 antibody <br /> loading control.                                                          study localization Pfnek-1 parasite <br />                                                                           asexual cycle. Fluorescent dots observed near nuclei <br /> Kinase assays. The assays performed standard reaction           ring schizont stages, pattern more <br /> (30 ml) containing 25 mM Tris/HCl, pH 7.5, 20 mM MgCl2, 2 mM              diffused appeared largely cytoplasmic trophozoites <br /> MnCl2, 10 mM ATP, 2.5 mCi [c-32P]ATP 5 mg casein (Sigma). The         (Fig. 1c). The anti-Pfnek-1 rabbit antibody able to <br /> reactions proceeded 30 min 30 uC stopped the <br />                                                                           immunoprecipitate b-casein kinase activity (Fig. 1d), <br /> addition Laemmli buffer, boiled 3 min analysed by <br /> electrophoresis 12 % SDS-PAGE gel. The gels dried           consistent previously published data demonstrating <br /> submitted autoradiography.                                             recombinant Pfnek-1 catalytic domain active <br />                                                                           substrate (Dorin et al., 2001). Pfnek-1 expression <br /> Medium-throughput screening. The Pfnek-1 kinase activity              activity asexual parasites confirmed using <br /> assayed purified GST-Pfnek-1 [100 ng purified            parasite lines expressing tagged enzyme (see below). <br /> described previously (Dorin et al., 2001)] 96-well microplates a <br /> standard kinase buffer (20 mM Tris/HCl pH 7.5, 20 mM MgCl2, <br /> 2 mM MnCl2) b-casein (9 mg) substrate, 10 mM b-                 A functional pfnek-1 gene required for <br /> glycerophosphate, 10 mM sodium fluoride 15 mM [c-33P]ATP           completion erythrocytic asexual cycle <br /> a final volume 50 ml. After 30 min incubation 30 uC, reaction <br /> was stopped filtration P81 phosphocellulose paper. Filters     To address question Pfnek-1 essentiality comple- <br /> washed 1 % phosphoric acid water. Scintillation fluid          tion asexual cycle, followed strategy used <br /> added, incorporation radioactive phosphate substrate      successfully P. falciparum kinases is <br /> was measured scintillation counter. Blanks (no kinase)          described (Doerig et al., 2010). Briefly, <br /> subtracted values. A library comprising 10 480 low- <br /> molecular-mass compounds obtained World Health <br />                                                                           3D7 parasites transfected plasmid based the <br /> Organization tested purified Pfnek-1. Five thousand       pCAM-BSD vector (Sidhu et al., 2005), central <br /> compounds derived known kinase inhibitory scaffolds.            fragment Pfnek-1 catalytic domain coding sequence <br /> Compounds screened final concentration 10 mM.          inserted way single crossover homologous <br />  <br /> http://mic.sgmjournals.org                                                                                                         2787 <br />  D. Dorin-Semblat others <br />  <br />  <br />  <br />  <br />        Fig. 1. Expression Pfnek-1 asexual parasites. (a) Western blot analysis detecting full-length protein. Asynchronous (i, <br />        chicken antibody) synchronous (ii, rabbit antibody) parasite extract (15 mg) loaded gels. Arrows indicate the <br />        position Pfnek-1. (b) Western blot analysis (rabbit antibody) showing antibody recognizes recombinant GST-Pfnek-1 <br />        (Dorin et al., 2001) (far right lane) displays loading control (antibody P. falciparum 2-Cys peroxiredoxin). R, Rings; <br />        T, trophozoites; S, schizonts. Molecular masses co-migrating markers indicated kDa. (c) Immunofluorescence analysis. <br />        Synchronized asexual parasites stained immunopurified rabbit anti-Pfnek-1 antibody (top panels). The bottom <br />        panels display negative controls using pre-immune serum. Bar, 5 mm. (d) Immunoprecipitated kinase activity. The anti-Pfnek-1 <br />        rabbit antibody used immunoprecipitate b-casein kinase activity 3D7 parasite extracts (lane 2). The pre-immune <br />        serum used control (lane 1). <br />  <br />  <br />  <br />  <br /> recombination pfnek-1 locus result                      locus recombine. To investigate possibility, we <br /> pseudo-diploid configuration, truncated                       transfected parasites pCAM-HA-Nek-1, pCAM-BSD <br /> copies coding sequence lack subdomain essential                    plasmid containing 39 end Pfnek-1 coding region <br /> for activity (Fig. 2a). The transfected parasites subjected            fused HA epitope, followed 39 untranslated <br /> to blasticidin selection, resulting resistant population            region P. berghei dhfr-ts gene. Recombination <br /> was examined PCR presence (i) wild-type                   genomic locus expected result the <br /> locus, (ii) episomal vector (iii) predicted                     formation functional locus expressing HA-tagged <br /> disrupted locus extremities inserted plasmid.                Pfnek-1 protein (plus inactive truncated copy) (Fig. 3a). <br /> Three independent transfections performed, did                  PCR (Fig. 3b) Southern blot (Fig. 3c) analyses <br /> not detect integration extended culture                    conducted 8 weeks post-transfection showed integ- <br /> blasticidin-resistant parasites (up 6 months); contrast,              ration occurred (and detected of <br /> we readily succeeded amplifying fragment                    transfected populations early 5 weeks post- <br /> wild-type episomal forms (Fig. 2b). Southern blot                       transfection nested PCR), demonstrating locus <br /> analysis used verify integrity locus                readily modified loss function incurred. <br /> several months culture blasticidin pressure (Fig. 2c).             The 6.8 .10 kb wild-type bands Southern blot <br />                                                                             (Fig. 3c, lanes 1) undetectable (uncloned) <br /> There possibility stage absence            transfected population; likewise, amplicons diagnostic for <br /> integration lack potential pfnek-1                 wild-type locus detected PCR. This <br />  <br /> 2788                                                                                                                            Microbiology 157 <br />                                                                                                           A male-specific Plasmodium kinase <br />  <br />  <br />  <br />  <br />       Fig. 2. Attempt disrupt pfnek-1 gene. (a) Strategy pfnek-1 gene disruption. The knockout vector contains PCR <br />       fragment spanning positions 73&#226;&#8364;&#8220;630 Pfnek-1 coding sequence, excluding kinase subdomains essential activity. <br />       Single crossover homologous recombination results pseudo-diploid configuration truncated copies lacking <br />       essential catalytic residues. The location PCR primers (numbered arrows) restriction sites used Southern blot <br />       analysis indicated. (b) PCR genotyping. Genomic DNA isolated transfected parental 3D7 parasites, and <br />       subjected PCR using indicated primers (see Fig. 2a). Lanes: 1, primers 1+3 (diagnostic 59 integration event, 0.6 kb); <br />       2, primers 2+4 (diagnostic 39 integration event, 1.5 kb); 3, primers 2+ 3 (diagnostic episome, 0.7 kb); 4, primers <br />       1+ 4 (diagnostic wild-type locus, 2.1 kb). Sizes co-migrating markers indicated kb. (c) Southern blot analysis of <br />       transfected parasites. Genomic DNA digested SpeI NcoI probed Pfnek-1 fragment used pCAM- <br />       BSD-Nek-1 vector (positions 73 630 coding sequence). Sizes co-migrating markers indicated kb. <br />  <br />  <br /> indicates parasites modified locus                      parasite development. Immunofluorescence <br /> overgrown wild-type locus containing                    analysis (IFA) using anti-HA antibodies confirmed the <br /> the episome, presumably subpopula-                 data obtained anti-Pfnek-1 antibody (Fig. 1), <br /> tion (but latter) daughter merozoites contain             showing expression asexual parasites, revealed <br /> the resistance cassette. An anti-HA antibody did                expression gametocytes (Fig. 4a). In gametocytes, <br /> any detectable signal mock-transfected parasites                 staining concentrate elongated structure on <br /> Western blot analysis, extracts transfected                 cell; instances FITC labelling seems <br /> population yielded signal expected size 125 kDa              accumulate gametocyte poles. This contrast <br /> (Fig. 3d). Immunoprecipitates obtained transfected                  Pfnek-2, labels clear microtubular structures in <br /> parasite extracts (but extracts wild-type              female gametocytes (Reininger et al., 2009). Interestingly, <br /> parental clone) anti-HA antibody contained casein               noticed small fraction (approx. 5 %, Table 1) <br /> kinase activity, confirming Pfnek-1 HA-                     gametocytes yielded HA signal, suggesting that <br /> tagging occurred did interfere enzymic                      expression Pfnek-1 restricted male <br /> function. Taken together, transfection data showing                  gametocytes. To test hypothesis, performed co- <br /> that pfnek-1 locus modified change                IFA gametocyte cultures mouse anti-HA <br /> does cause loss function demonstrate Pfnek-1                 antibodies rat antibody directed Pfg377, a <br /> plays important role erythrocytic asexual cycle.               protein associated osmiophilic bodies is <br />                                                                          preferentially expressed female gametocytes (Alano et al., <br />                                                                          1995; Koning-Ward et al., 2008), using anti-mouse and <br /> Sex specificity Pfnek-1 expression <br />                                                                          anti-rat secondary antibodies conjugated FITC (green) <br /> The availability parasite populations expressing HA-                  rhodamine (red), respectively. The outcome this <br /> tagged Pfnek-1 allowed protein expression monitored                experiment clear: Pfg377-positive (red) gametocytes <br />  <br /> http://mic.sgmjournals.org                                                                                                               2789 <br />  D. Dorin-Semblat others <br />  <br />  <br />  <br />  <br />        Fig. 3. HA tagging pfnek-1 locus. (a) Strategy HA tagging. The locations primers used PCR diagnostics are <br />        indicated numbered arrows, positions restriction sites used Southern blot analysis shown. (b) PCR <br />        genotyping analysis. Genomic DNA isolated pCAM-HA-nek-1-transfected parasites parental 3D7 parasites, <br />        subjected PCR using indicated primers (see Fig. 3a). Lanes: 1, primers 1+7 (diagnostic 59 integration event, <br />        1.2 kb); 2, primers 6+3 (diagnostic 39 integration event, 1.2 kb); 3, primers 6+4 (diagnostic 39 integration event, <br />        1.5 kb); 4, primers 1+4 (diagnostic wild-type locus, 1.5 kb). Sizes co-migrating markers indicated kb. (c) Southern <br />        blot analysis transfected parasites. Total DNA digested StuI HindIII (i) StuI BamHI (ii) probed a <br />        fragment spanning nucleotides 577&#226;&#8364;&#8220;1155 pfnek-1 coding region. Sizes co-migrating markers indicated kb. (d) <br />        Western blot analysis HA-tagged Pfnek-1. Protein extracts (15 mg) parental 3D7 wild-type clone (lane 1) and <br />        pCAM-HA-nek-1-transfected parasites (lane 2) probed anti-HA antibody. Sizes co-migrating markers are <br />        indicated kDa. (e) Anti-HA antibodies immunoprecipitate kinase activity transfected parasites. Anti-HA antibodies were <br />        incubated extracts parental 3D7 wild-type clone (lane 2) pCAM-HA-Nek-1-transfected parasites (lane 3). <br />        Immunoprecipitated material assayed b-casein activity. Lane 1 shows kinase assay b-casein (no <br />        immunoprecipitate added), molecular mass marker shown lane 4. Molecular masses indicated kDa. <br />  <br />  <br />  <br /> did display FITC (green) staining, FITC-                   microscopic field illustrates the <br /> positive cells faintly stained Pfg377              largely mutually exclusive green&#226;&#8364;&#8220;red staining. Additional <br /> antibody (Fig. 4b). Fig. 4(c) presents gametocytes                     representative examples shown Fig. 4(d). We found <br />  <br /> 2790                                                                                                                         Microbiology 157 <br />                                                                                                        A male-specific Plasmodium kinase <br />  <br />  <br />  <br />  <br />       Fig. 4. Immunofluorescence analyses male female gametocytes. (a) Detection HA-Pfnek-1 asexual parasites (line 2) <br />       gametocytes (lines 3 4) transfected pCAM-HA-Nek-1 using anti-HA antibody. The line shows negative <br />       control (staining wild-type parasites anti-HA antibody). Bar, 10 mm. (b) A single microscopic field presented, <br />       showing mutually exclusive staining antibodies. DAPI (blue), anti-mouse&#226;&#8364;&#8220;FITC (green) anti-rat&#226;&#8364;&#8220;rhodamine <br />       (red) secondary antibodies used. (c) Tubulin expressed predominantly male gametocytes. Co-staining performed <br />       a-tubulin antibody antibody Pfg377, protein expressed predominantly female gametocytes. (d) <br />       Further examples sex-specificity HA-Pfnek-1 expression. (e) Typical images Giemsa-stained stage V gametocytes, <br />       used determine sex ratio Table 1. Bar, 10 mm. =, Male; R, female. <br />  <br />  <br />  <br /> that approximately 95 % gametocytes gave strong                specifically male gametocytes late stages (IV V) <br /> Pfg377 (red) signal, remaining 5 % showed                     gametocytogenesis (Fig. 4c Table 1). Taken together, <br /> evidence HA-Pfnek-1 expression (green) (Table 1). This               data demonstrate (i) Pfnek-1 expressed in <br /> is similar sex ratio measured cultures           male gametocytes, line conclusion reached by <br /> of parental wild-type 3D7 parasites using Giemsa             Khan co-workers P. berghei orthologue of <br /> staining, allows sexing mature gametocytes                     Pfnek-1 basis mass spectrometry analysis of <br /> (Schwank et al., 2010) (Fig. 4e Table 1), staining               purified male female gametocyte populations (Khan <br /> with anti-a-tubulin antibodies, shown react                et al., 2005), (ii) C-terminal HA tag did not <br />  <br /> http://mic.sgmjournals.org                                                                                                            2791 <br />  D. Dorin-Semblat others <br />  <br />  <br /> Table 1. Sex ratio gametocyte cultures, determined using various methods <br /> Male female gametocytes counted smears following stages: stages IV V labelling HA-Pfnek-1 transgenic parasites with <br /> antibodies HA Pfg377; stage V Giemsa-stained gametocytes wild-type 3D7 clone; stages IV V labelling gametocytes of <br /> the wild-type 3D7 clone antibodies a-tubulin Pfg377. See text details. <br />  <br />                                        No. female gametocytes                     No. male gametocytes                      Sex ratio (%)* <br />  <br />  Pfg377/HaNek1                                  155 (red)                                      8 (green)                                  5 <br />  Giemsa stain                                   117 (blue)                                     8 (pink)                                   6.4 <br />  Pfg377/Tubulin                                 235 (red)                                     21 (green)                                  8 <br />  <br /> *Male/(male+female)6100. <br />  <br />  <br />  <br /> affect sex ratio hence, presumably, function                 recombinant enzymes share properties are <br /> Pfnek-1 male gametocytes.                                                required screening operations (Dorin et al., 2001; <br />                                                                             Reininger et al., 2005, 2009). Thus, NIMA-related kinases <br />                                                                             represent genetically validated targets multi-pronged <br /> Potential antimalarial drug discovery <br />                                                                             approach multiple stages parasite life cycle. <br /> Our reverse genetics data validate Pfnek-1 potential <br /> drug target antimalarial chemotherapy. To provide a <br /> proof-of-concept recombinant protein used                   ACKNOWLEDGEMENTS <br /> in screening operations, performed medium-through- <br />                                                                             We thank Jean Halbert HA tagging vector, Sylke Mu&#194;&#168;ller the <br /> put screen library small molecules recombinant                   PfTrX antibody Pietro Alano Pfg377 antibody. We thank <br /> GST-Pfnek-1 (see Methods). Of 10 480 compounds tested,                      T. Laroche L. C. Floyd Sarria (EPFL BiOP Platform), Neeraj <br /> 23 showed 50 % inhibition 10 mM. This low hit                  Dhar Maglica Zeljka (EPFL UPKIN laboratory) help with <br /> rate (0.22 %) illustrates specificity Pfnek-1                    imaging. Work C. D.&#226;&#8364;&#8482;s laboratory supported INSERM, EPFL <br /> inhibition assay. IC50 values determined ranged                    Framework Programmes European Commission (FP6 <br /> <span id='am-1' about='protege:FROM' typeof='owl:Thing'>from</span> 0.85 10 mM (data shown; detailed results                   project ANTIMAL, FP7 project MALSIG FP6/P7 Network of <br />                                                                             Excellence BioMalPar/EviMalar). Work D. C.&#226;&#8364;&#8482;s laboratory is <br /> the screen post-screen hit characterization outside <br />                                                                             funded grant National Institutes Health <br /> the scope study published elsewhere). This              (AI73795). The screening Pfnek-1 supported World <br /> indicates activity recombinant Pfnek-1                      Health Organization. <br /> catalytic domain sufficient run screening programs, <br /> extending smaller-scale studies compounds from <br /> natural sources inhibit recombinant Pfnek-1                   REFERENCES <br /> (Desoubzdanne et al., 2008; Laurent et al., 2006). A <br /> promising avenue follow screen Pfnek-1                    Abdi, A., Eschenlauer, S., Reininger, L. &amp; Doerig, C. (2010). SAM <br /> (and P. falciparum kinases) so-called &#226;&#8364;&#732;malaria                    domain-dependent activity PfTKL3, essential tyrosine kinase- <br /> boxes&#226;&#8364;&#8482;, collections compounds identified cellular                     like kinase human malaria parasite Plasmodium falciparum. Cell <br /> screens possessing selective parasiticidal activity (Gamo                Mol Life Sci 67, 3355&#226;&#8364;&#8220;3369. <br /> et al., 2010; Guiguemde et al., 2010; Plouffe et al., 2008).                Alano, P, Read, D., Bruce, M., Aikawa, M., Kaido, T., Tegoshi, T., <br /> Interestingly, Pfnek-1 predicted chemoinformatics                  Bhatti, S., Smith, D. K., Luo, C. &amp; authors (1995). COS cell <br /> basis target the hit compounds                expression cloning Pfg377, Plasmodium falciparum gametocyte <br />                                                                             antigen associated osmiophilic bodies. Mol Biochem Parasitol 74, <br /> malaria box GlaxoSmithKline study (Gamo et al., <br />                                                                             143&#226;&#8364;&#8220;156. <br /> 2010). <br />                                                                             Anamika, S., Srinivasan, N &amp; Krupa, A. (2005). A genomic perspective <br />                                                                             protein kinases Plasmodium falciparum. Proteins 58, 180&#226;&#8364;&#8220; <br /> Since Pfnek-1 known expressed male <br />                                                                             189. <br /> gametocytes Pfnek-2 -4 female gametocytes <br />                                                                             Carter, R., Ranford-Cartwright, L. &amp; Alano, P (1993). The culture and <br /> (and meiosis-related phenotypes Pbnek-2 <br />                                                                             preparation gametocytes Plasmodium falciparum immuno- <br /> and -4 carried female gametocytes/gametes),                          chemical, molecular, mosquito infectivity studies. Methods Mol <br /> interference Nek function represents potential                       Biol 21, 67&#226;&#8364;&#8220;88. <br /> avenue transmission blocking curative                        Carvalho, T. G. &amp; Me&#194;&#180;nard, R. (2005). Manipulating Plasmodium <br /> intervention. Because relatedness enzymes                   genome. Curr Issues Mol Biol 7, 39&#226;&#8364;&#8220;55. <br /> to other, inhibitors affecting enzyme of <br />                                                                             Koning-Ward, T. F., Olivieri, A., Bertuccini, L., Hood, A., Silvestrini, F., <br /> the family conceivably identified. The benefits                 Charvalias, K., Berzosa D&#196;&#177;&#194;&#180;az, P., Camarda, G., McElwain, T. F. &amp; other <br /> multi-target strategies treatment kinase inhibitors                authors (2008). The role osmiophilic bodies Pfg377 expression in <br /> have discussed contexts (for example,                     female gametocyte emergence mosquito infectivity human <br /> Sathornsumetee &amp; Reardon, 2009). The Pfnek-1, -2 -4                     malaria parasite Plasmodium falciparum. Mol Microbiol 67, 278&#226;&#8364;&#8220;290. <br />  <br /> 2792                                                                                                                                  Microbiology 157 <br />                                                                                                                        A male-specific Plasmodium kinase <br />  <br />  <br /> Desoubzdanne, D., Marcourt, L., Raux, R., Chevalley, S., Dorin, D.,               Lambros, C. &amp; Vanderberg, J P. (1979). Synchronization Plasmodium <br /> Doerig, C., Valentin, A., Ausseil, F. &amp; Debitus, C. (2008).                       falciparum erythrocytic stages culture. J Parasitol 65, 418&#226;&#8364;&#8220;420. <br /> Alisiaquinones alisiaquinol, dual inhibitors Plasmodium                    Laurent, D., Jullian, V., Parenty, A., Knibiehler, M., Dorin, D., Schmitt, S., <br /> falciparum enzyme targets New Caledonian deep water                        Lozach, O., Lebouvier, N., Frostin, M. &amp; Alby, F. (2006). Antimalarial <br /> sponge. J Nat Prod 71, 1189&#226;&#8364;&#8220;1192.                                                 potential xestoquinone, protein kinase inhibitor isolated a <br /> Doerig, C., Abdi, A., Bland, N., Eschenlauer, S., Dorin-Semblat, D.,              Vanuatu marine sponge Xestospongia sp. Bioorg Med Chem 14, 4477&#226;&#8364;&#8220; <br /> Fennell, C., Halbert, J., Holland, Z., Nivez, M. P. &amp; authors               4482. <br /> (2010). Malaria: targeting parasite host cell kinomes. Biochim                Le Roch, K. G., Zhou, Y., Blair, P. L., Grainger, M., Moch, J. K., <br /> Biophys Acta 1804, 604&#226;&#8364;&#8220;612.                                                       Haynes, J. D., De La Vega, P., Holder, A. A., Batalov, S. &amp; other <br /> Dorin, D, Le Roch, K., Sallicandro, P., Alano, P., Parzy, D., Poullet, P.,        authors (2003). Discovery gene function expression profiling of <br /> Meijer, L. &amp; Doerig, C. (2001). Pfnek-1, NIMA-related kinase               malaria parasite life cycle. Science 301, 1503&#226;&#8364;&#8220;1508. <br /> the human malaria parasite Plasmodium falciparum. Biochemical                     Le Roch, K. G., Johnson, J. R., Florens, L., Zhou, Y., Santrosyan, A., <br /> properties possible involvement MAPK regulation. Eur J                     Grainger, M., Yan, S. F., Williamson, K. C., Holder, A. A. &amp; other <br /> Biochem 268, 2600&#226;&#8364;&#8220;2608.                                                           authors (2004). Global analysis transcript protein levels across <br /> Dorin, D, Semblat, J. P., Poullet,  <br /> </body></html>